| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
127,470,000 |
| Market
Cap: |
1.66(B) |
| Last
Volume: |
878,666 |
Avg
Vol: |
1,074,261 |
| 52
Week Range: |
$11.665 - $20.73 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,049 |
9,748 |
12,417 |
12,417 |
| Total Sell Value |
$16,511 |
$152,803 |
$201,886 |
$201,886 |
| Total People Sold |
1 |
2 |
2 |
2 |
| Total Sell Transactions |
1 |
3 |
4 |
4 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shovlin Robert J. |
President, Clinical Services |
• – – |
2019-11-01 |
4 |
S |
$22.74 |
$814,115 |
D/D |
(35,801) |
145,640 |
|
- |
|
| Johnson Kevin C |
Director |
– • – |
2019-10-31 |
4 |
OE |
$4.78 |
$191,241 |
D/D |
24,683 |
52,968 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2019-10-31 |
4 |
S |
$23.11 |
$1,628,631 |
D/D |
(70,473) |
181,441 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2019-10-31 |
4 |
OE |
$8.03 |
$772,213 |
D/D |
96,166 |
251,914 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-09-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,400 |
43,057 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-09-10 |
4 |
S |
$21.47 |
$25,764 |
I/I |
(1,200) |
46,457 |
|
- |
|
| Hannah Alison L. |
Director |
– • – |
2019-09-09 |
4 |
OE |
$6.66 |
$98,111 |
D/D |
11,666 |
76,098 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-09-09 |
4 |
S |
$25.00 |
$75 |
I/I |
(3) |
1,676,230 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-09-06 |
4 |
S |
$25.00 |
$42,275 |
I/I |
(1,691) |
1,676,233 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-08-30 |
4 |
S |
$25.00 |
$30,000 |
I/I |
(1,200) |
1,677,924 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• • – |
2019-08-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
2,016,589 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• • – |
2019-08-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• • – |
2019-08-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
2,026,589 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-08-28 |
4 |
S |
$25.02 |
$989,216 |
I/I |
(39,537) |
1,679,124 |
|
- |
|
| Bonello William |
Chief Strategy Officer |
• – – |
2019-08-28 |
4 |
S |
$24.83 |
$422,110 |
D/D |
(17,000) |
6,735 |
|
- |
|
| Bonello William |
Chief Strategy Officer |
• – – |
2019-08-28 |
4 |
OE |
$7.52 |
$127,840 |
D/D |
17,000 |
23,735 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-08-27 |
4 |
S |
$24.95 |
$755,486 |
I/I |
(30,280) |
1,718,661 |
|
- |
|
| Hipp Raymond R |
Director |
– • – |
2019-08-26 |
4 |
S |
$24.79 |
$382,361 |
D/D |
(15,424) |
134,102 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-08-26 |
4 |
S |
$24.87 |
$3,571,407 |
I/I |
(143,603) |
1,748,941 |
|
- |
|
| Johnson Kevin C |
Director |
– • – |
2019-08-26 |
4 |
S |
$24.74 |
$291,932 |
D/D |
(11,800) |
28,285 |
|
- |
|
| Hipp Raymond R |
Director |
– • – |
2019-08-23 |
4 |
S |
$25.02 |
$15,012 |
D/D |
(600) |
149,526 |
|
- |
|
| Hipp Raymond R |
Director |
– • – |
2019-08-23 |
4 |
OE |
$7.27 |
$84,527 |
D/D |
9,127 |
150,126 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2019-08-23 |
4 |
S |
$25.72 |
$191,768 |
I/I |
(7,456) |
1,892,544 |
|
- |
|
| Johnson Kevin C |
Director |
– • – |
2019-08-23 |
4 |
S |
$25.60 |
$1,054,720 |
D/D |
(41,200) |
40,085 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• • – |
2019-08-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,090) |
2,010,499 |
|
- |
|
544 Records found
|
|
Page 10 of 22 |
|
|
0.12 (0.91%) 
